Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices 71367 

Respondent Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Non-responding SSPs ................................... Non-Response Survey Item .......................... 1000 1 2/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–22777 Filed 10–13–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10241 and CMS– 

10717] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by November 15, 

2023. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Survey of Retail 

Prices; Use: This information collection 

request provides for a survey of the 

average acquisition costs of all covered 

outpatient drugs purchased by retail 

community pharmacies. CMS may 

contract with a vendor to conduct 

monthly surveys of retail prices for 

covered outpatient drugs. Such prices 

represent a nationwide average of 

consumer purchase prices, net of 

discounts and rebates. The contractor 

shall provide notification when a drug 

product becomes generally available 

and that the contract includes such 

terms and conditions as the Secretary 

shall specify, including a requirement 

that the vendor monitor the 

marketplace. CMS has developed a 

National Average Drug Acquisition Cost 

(NADAC) for states to consider when 

developing reimbursement 

methodology. The NADAC is a pricing 

benchmark that is based on the national 

average costs that pharmacies pay to 

acquire Medicaid covered outpatient 

drugs. This pricing benchmark is based 

on drug acquisition costs collected 

directly from pharmacies through a 

nationwide survey process. This survey 

is conducted on a monthly basis to 

ensure that the NADAC reference file 

remains current and up-to-date. Form 

Number: CMS–10241 (OMB control 

number 0938–1041); Frequency: 

Monthly; Affected Public: Private sector 

(Business or other for-profits); Number 

of Respondents: 72,000; Total Annual 

Responses: 72,000; Total Annual Hours: 

36,000. (For policy questions regarding 

this collection contact: Robert Giles at 

667–290–8626.) 

2. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Medicare Part C 

and Part D Program Audit and IndustryWide Part C Timeliness Monitoring 

Project (TMP) Protocols; Use: Under the 

Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003 and implementing regulations at 

42 CFR parts 422 and 423, Medicare 

Part D plan sponsors and Medicare 

Advantage organizations are required to 

comply with all Medicare Parts C and D 

program requirements. CMS’ annual 

audit plan ensures that we evaluate 

sponsoring organizations’ compliance 

with these requirements by conducting 

program audits that focus on high-risk 

areas that have the greatest potential for 

beneficiary harm. As such, CMS has 

developed the following audit protocols 

for use by sponsoring organizations to 

prepare for their audit: 

• Compliance Program Effectiveness 

(CPE) 

• Part D Formulary and Benefit 

Administration (FA) 

• Part D Coverage Determinations, 

Appeals, and Grievances (CDAG) 


ddrumheller on DSK120RN23PROD with NOTICES1
71368 Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices 

• Part C Organization Determinations, 

Appeals, and Grievances (ODAG) 

• Special Needs Plans Care 

Coordination (SNPCC) 

CMS generally conducts program 

audits at the parent organization level in 

an effort to reduce burden and, for 

routine audits, subjects each sponsoring 

organization to all applicable program 

area protocols. For example, if a 

sponsoring organization does not offer a 

special needs plan, or an accrediting 

organization has deemed a special needs 

plan compliant with CMS regulations 

and standards, CMS would not apply 

the SNPCC protocol. Likewise, CMS 

would not apply the ODAG audit 

protocol to an organization that offers 

only a standalone prescription drug 

plan since that organization does not 

offer the MA benefit. Conversely, ad hoc 

audits resulting from referral may be 

limited in scope and, therefore, all 

program area protocols may not be 

applied. 

The information gathered during this 

program audit will be used by the 

Medicare Parts C and D Oversight and 

Enforcement Group (MOEG) within the 

Center for Medicare (CM) and CMS 

Regional Offices to assess sponsoring 

organizations’ compliance with 

Medicare program requirements. If 

outliers or other data anomalies are 

detected, Regional Offices will work in 

collaboration with MOEG and other 

divisions within CMS for follow-up and 

resolution. Additionally, MA and Part D 

organizations will receive the audit 

results and will be required to 

implement corrective action to correct 

any identified deficiencies. Form 

Number: CMS–10717 (OMB control 

number: 0938–1395); Frequency: Yearly; 

Affected Public: Private Sector, State, 

Local, or Tribal Governments, Federal 

Government, Business or other forprofits, Not-for-Profit Institutions; 

Number of Respondents: 182; Total 

Annual Responses: 182; Total Annual 

Hours: 36,444. (For policy questions 

regarding this collection contact 

Matthew Guerand, at 303–844–7120.) 

Dated: October 11, 2023. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2023–22791 Filed 10–13–23; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Notice of Fiscal Year 2023 Health 

Center Program COVID–19 HHS Bridge 

Access Program Funding Awards 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice of funding awards. 

SUMMARY: In support of the HHS Bridge 

Access Program for COVID–19 Vaccines 

and Treatments, HRSA provided more 

than $81 million in one-time funding to 

all current Health Center Program 

operational (H80) award recipients and 

to health center look-alikes that 

previously received American Rescue 

Plan funding (L2C awards). 

FOR FURTHER INFORMATION CONTACT: 

Olivia Shockey, Expansion Division 

Director, HRSA, at oshockey@hrsa.gov 

and (301) 594–4300. 

SUPPLEMENTARY INFORMATION: 

Intended Recipient of the Award: The 

total amount of funding, number of 

awards, and award recipients can be 

found here: https://bphc.hrsa.gov/ 

funding/coronavirus-related-funding/ 

covid-19-bridge-funding/fy-2023- 

awards. 

Project Period: September 1, 2023— 

December 31, 2024. 

CFDA Number: 93.527. 

Authority: Section 2401 of the 

American Rescue Plan Act of 2021, 

Public Law 117–2. 

Justification: The end of the declared 

COVID–19 Public Health Emergency 

and associated transition to commercial 

access to vaccines and therapeutics 

impacts the capacity of health centers to 

maintain essential COVID–19 related 

services for their patients, including but 

not limited to health center patients 

who lack health insurance. Health 

centers will use one-time Bridge 

funding to support uninsured and 

underinsured patients and residents of 

their communities with needs such as 

COVID–19 vaccination and 

therapeutics, enabling/patient support 

services (such as outreach, education, 

enrollment assistance, transportation, 

translation, and care coordination) to 

support COVID–19 related services; 

community COVID–19 vaccination 

events; and, supplies and personnel 

who support COVID–19 related services 

and care delivery, including personnel 

costs necessary to develop, support, or 

expand collaborations, including 

collaborations with state/jurisdiction 

immunization programs. Recipients will 

submit data on program activities 

through the HRSA Health Center 

COVID–19 survey as required, as well as 

periodic progress reports. 

Carole Johnson, 

Administrator. 

[FR Doc. 2023–22751 Filed 10–13–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Advisory Council on Alzheimer’s 

Research, Care, and Services; Meeting 

AGENCY: Assistant Secretary for 

Planning and Evaluation, HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces the 

public meeting of the Advisory Council 

on Alzheimer’s Research, Care, and 

Services (Advisory Council). The 

Advisory Council provides advice on 

how to prevent or reduce the burden of 

Alzheimer’s disease and related 

dementias (ADRD) on people with the 

disease and their caregivers. During the 

meeting on October 30, 2023, the 

Advisory Council will welcome a new 

cohort of members and hear updates 

from federal agencies on key activities 

over the last quarter. A panel will 

present information on interventions to 

reduce the risk of developing dementia. 

DATES: The meeting will be held 

virtually on October 30 from 12 p.m. to 

4:30 p.m. EDT. 

ADDRESSES: The meeting will be virtual. 

It will stream live at www.hhs.gov/live. 

Comments: Time is allocated on the 

agenda to hear public comments from 4 

p.m. to 4:30 p.m. The time for oral 

comments will be limited to two (2) 

minutes per individual. In order to 

provide a public comment, please 

register by emailing your name to 

napa@hhs.gov by Thursday, October 26. 

Registered commenters will receive both 

a dial-in number and a link to join the 

meeting virtually; individuals will have 

the choice to either join virtually via the 

link, or to call in only by using the dialin number. Note: There may be a 30–45 

second delay in the livestream video 

presentation of the conference. For this 

reason, if you have pre-registered to 

submit a public comment, it is 

important to connect to the meeting by 

3:45 p.m. to ensure that you do not miss 

your name and allotted time when 

called. If you miss your name and 

allotted time to speak, you may not be 

able to make your public comment. All 

participant audio lines will be muted for 

the duration of the meeting and only 

unmuted by the Host at the time of the 


ddrumheller on DSK120RN23PROD with NOTICES1